1,039 reports of this reaction
1.8% of all MEDROXYPROGESTERONE ACETATE reports
#6 most reported adverse reaction
NAUSEA is the #6 most commonly reported adverse reaction for MEDROXYPROGESTERONE ACETATE, manufactured by Pharmacia & Upjohn Company LLC. There are 1,039 FDA adverse event reports linking MEDROXYPROGESTERONE ACETATE to NAUSEA. This represents approximately 1.8% of all 57,188 adverse event reports for this drug.
Patients taking MEDROXYPROGESTERONE ACETATE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for MEDROXYPROGESTERONE ACETATE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for MEDROXYPROGESTERONE ACETATE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 1,039 FDA reports for MEDROXYPROGESTERONE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 1.8% of all adverse event reports for MEDROXYPROGESTERONE ACETATE, making it a notable side effect.
If you experience nausea while taking MEDROXYPROGESTERONE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.